CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

GlobeNewswireNov 27 08:00 ET

Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics (CTMX) Looks Ripe for a Turnaround

Zacks Nov 19 08:40 ET

Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $3.25

Moomoo NewsNov 8 11:31 ET · Ratings

CytomX Therapeutics Price Target Lowered to $3.25 From $3.50 at Piper Sandler

TipRanksNov 8 10:40 ET

CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 8 08:59 ET · Conference Call

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaNov 8 07:05 ET